Pfizer
Grace Mendoza Cole has extensive work experience in the pharmaceutical industry. Grace currently holds the position of Director, Clinical Study Team Lead at Pfizer, starting in March 2021. Prior to this role, they worked as a Project Director at Syneos Health from August 2018 to March 2021. Grace also served as a Clinical Operations Lead, Hematology at Spark Therapeutics, Inc. from May 2017 to June 2018. Grace has held various positions at CSL Behring, including Associate Director, Clinical Trial Process Improvement and Innovation from November 2016 to May 2017, and Sr. Clinical Program Manager from August 2012 to November 2016. Grace has also worked as a Sr. Clinical Project Manager at Pfizer from May 2011 to August 2012 and as a Senior Global Study Manager at GlaxoSmithKline from March 2009 to July 2010. Grace's earlier experience includes roles such as Assistant Director, Global Trial Leader at Pfizer, Wyeth from December 2001 to March 2009, CRA at inVentiv Health Clinical from March 2000 to December 2001, Scientist II at Wyeth-Ayerst Research from November 1996 to March 2000, and Research Teaching Specialist at the University of Medicine and Dentistry of New Jersey from December 1992 to August 1996.
Grace Mendoza Cole holds a B.S. degree in Biology from Rider University.
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.